Key facts
- Minze’s last known valuation is $13.0M.
- It has raised $10.5M; the latest was Later Stage VC ($5.3M) in Oct 2024.
- Notable investors include Imec.istart, Noshaq, Participatiemaatschappij Vlaanderen, Start it @KBC, Capricorn Partners — 9 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 9 names
- ·Watchlist + deal alerts for Minze
- ·The full record, as it builds
Funding rounds
No funding rounds for Minze are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Minze
Developer of digital health system designed to focus on urologic, pelvic health, and continence care. The company's platform helps in the diagnostic, treatment, and remote patient monitoring for people suffering from lower urinary tract symptoms (LUTS), enabling urologists to diagnose and monitor patients in the hospital or private practice.
- Sector
- Healthcare
- HQ
- Antwerp, Belgium
- Founded
- 2015
- Employees
- 26
- Website
- minzehealth.com/
- Ownership
- Privately Held (backing)
Minze doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Minze shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Minze in its N-PORT filings yet. We sweep new filings monthly.